Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Illumina, Inc.
This is a prospective multicenter study in which whole blood specimens will be collected from pregnant women scheduled for an invasive procedure.
After the standard-of-care invasive procedure is performed in accordance with the site's clinical procedures, invasive prenatal diagnostic procedure results will also be collected.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Be 18 years of age or older at enrollment,
Has a viable pregnancy (with documented fetal heartbeat) of at least 10 weeks, 0 days gestation at the time of maternal specimen collection,
Be scheduled for an invasive prenatal diagnostic procedure (either chorionic villus sampling \[CVS\], amniocentesis, or percutaneous umbilical cord blood sampling \[cordocentesis\]) for cytogenetic analysis of the fetus
You may not be if
Has a known maternal chromosomal anomaly,
Had an invasive prenatal diagnostic procedure in the current pregnancy before maternal specimen collection
Has a history of transplant or malignancy, or
Had a transfusion of blood or blood components up to 8 weeks before maternal whole blood specimen collection
Already participated in this study (enrolled previously).
Clareo Health | Collection of Whole Blood Specimens in Pregnant Women
